Document Details
Form
Filing Date
Oct 16, 2019
Document Date
Jan 14, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Xeris Biopharma Holdings, Inc.
Issuer
XERIS PHARMACEUTICALS INC
Filer
PRESTRELSKI STEVEN